Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® ...

DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study EPITOPE OLE data demonstrates continued improvement in treatment ...

Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study EPITOPE OLE data demonstrates continued ...

Researchers find patterns in anaphylaxis symptoms that could help people manage their health risks Findings of a new study ...

An allergic reaction in babies can range from mild to life-threatening. Here’s how to tell if your child is having an ...

Food safety watchdogs stuck a 'do not eat' alert on four batches of the sweet treat made by Sultans. It is feared the ...

Canada and United Kingdom represent two of the largest markets within the ALK portfolio with plans to expand filings of neffy ...

Aquestive Therapeutics' Anaphylm is nearing FDA approval, potentially disrupting the U.S. anaphylaxis market dominated by ...

A recent study from McGill University provides important insights into severe allergic reactions, offering a warning for people with tree nut allergies and shedding light on broader patterns in ...

A daily cream containing a GluK2-activating compound could therefore be a promising way to prevent several inflammatory skin conditions.

According to a new study, specific anaphylactic triggers are associated with specific symptoms and treatments.